VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
BIOXBioceres Crop Solutions Corp.
$0.37$24M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBIOXRevenue History

BIOX logoBioceres Crop Solutions Corp. (BIOX) Revenue History

Annual and quarterly revenue from 2017 to present

TTM Revenue$285.1M▼ $48.2M vs FY2025
YoY Growth-25.5%Declining
Q2 2026$73.7M-25.5% YoY · -4.9% QoQ
Revenue CAGR
3Y+0.5%
→
5Y+14.1%
→
10Y—
Growth decelerating ↓
Best Fiscal Year$464.8M (2024)
Best Quarter$140.3M (Q2 2024)
Revenue per Share$4.51
Revenue per Employee$713K

BIOX Revenue Over Time (2017–2025)

BIOX Revenue Growth History

7 of 8 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
2017—
2018+42.5%
2019+20.1%
2020+7.5%
2021+19.9%
2022+58.9%
2023+27.7%
2024+10.8%
2025-28.3%
FY2017 revenue growth
N/A
FY2018 revenue growth
+42.5%
FY2019 revenue growth
+20.1%
FY2020 revenue growth
+7.5%
FY2021 revenue growth
+19.9%
FY2022 revenue growth
+58.9%
FY2023 revenue growth
+27.7%
FY2024 revenue growth
+10.8%
FY2025 revenue growth
-28.3%
DeclineStrong growth
↓ 1-year revenue declineBest: +58.9% (FY2022)Worst: -28.3% (FY2025)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q2 2026$73.7M-25.5%
Q1 2026$77.4M-16.4%
Q4 2025$74.4M-40.2%
Q3 2025$59.6M-29.1%
Q2 2025$98.9M-29.5%
Q1 2025$92.6M-20.3%
Q4 2024$124.3M+18.3%
Q3 2024$84.0M-9.7%
Seasonal Revenue Pattern (fiscal quarters)
Q1
24%
Q2
31%
Q3
17%
Q4
28%

Multi-year avg. share of annual revenue by fiscal quarter

Revenue Breakdown

BIOX's revenue distribution by segment and geography

By Geography

Argentina80.6%
North America10.5%
Brazil6.2%
Europe, Middle East and Africa2.8%

BIOX Revenue Analysis (2017–2025)

Current Revenue & Growth

As of June 22, 2026, Bioceres Crop Solutions Corp. (BIOX) generated trailing twelve-month (TTM) revenue of $285.1 million, reflecting significant decline in growth of -25.5% year-over-year. The most recent quarter (Q2 2026) recorded $73.7 million in revenue, down 4.9% sequentially.

Historical Growth Trajectory

BIOX's 5-year compound annual growth rate (CAGR) stands at +14.1%, indicating consistent double-digit revenue growth. The 3-year CAGR of +0.5% is below the 5-year average, signalling a growth deceleration in recent years. Bioceres Crop Solutions Corp.'s highest annual revenue of $464.8 million was recorded in 2024.

Peer Comparison

Compared to Basic Materials sector peers — including PGEN (+652.1% YoY), FMC (-16.6% YoY), and CTVA (+6.3% YoY) — BIOX has underperformed the peer group in revenue growth. Compare BIOX vs PGEN →

BIOX Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
BIOX logoBIOXCurrent$285M-25.5%+14.1%-1.1%
PGEN logoPGEN$10M+652.1%-21.3%-1100.8%
FMC logoFMC$3.5B-16.6%-5.7%-54.4%
CTVA logoCTVA$17.4B+6.3%+4.1%15.1%
AVD logoAVD$515M-1.0%+2.3%2.7%
HALO logoHALO$1.4B+39.1%+39.2%58.4%
Best in groupLowest in group

BIOX Historical Revenue Data (2017–2025)

1–9 of 9 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$333.3M-28.3%$130.2M39.1%$-3,700,000-1.1%
2024$464.8M+10.8%$181.6M39.1%$44.8M9.6%
2023$419.4M+27.7%$180.2M43.0%$54.2M12.9%
2022$328.5M+58.9%$126.4M38.5%$39.9M12.1%
2021$206.7M+19.9%$90.9M44.0%$38.4M18.6%
2020$172.4M+7.5%$79.5M46.1%$39.1M22.7%
2019$160.3M+20.1%$73.6M45.9%$32.1M20.0%
2018$133.5M+42.5%$56.4M42.2%$15.7M11.8%
2017$93.7M-$33.8M36.1%$-706,924-0.8%
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

9+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

BIOX — Frequently Asked Questions

Quick answers to the most common questions about buying BIOX stock.

Is BIOX's revenue growth accelerating or slowing?

BIOX revenue is declining -25.5% year-over-year. TTM revenue fell to $285M, contrasting with the 5-year CAGR of +14.1%. The reversal reflects either macro headwinds or company-specific challenges.

What is BIOX's revenue history from 2017 to 2026?

Bioceres Crop Solutions Corp. (BIOX) revenue history spans 2017 to 2026. TTM revenue as of 2026 is $285M, growing at -25.5% YoY. The 5-year CAGR is +14.1%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is BIOX's long-term revenue growth rate (CAGR)?

Bioceres Crop Solutions Corp.'s 5-year revenue CAGR of +14.1% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -25.5% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for BIOX.

Why does BIOX's quarterly revenue fluctuate?

BIOX quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Bioceres Crop Solutions Corp.'s revenue data from 2017 to 2026 shows full historical quarterly detail on this page.

How is BIOX's revenue distributed by segment?

BIOX reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does BIOX's revenue compare to industry peers?

Bioceres Crop Solutions Corp. (BIOX) with TTM revenue of $285M and -25.5% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.